Showing all 5 results
Chlorambucil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Cytotoxic Tablet, packed exclusively in light-shielded, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the sensitive aromatic mustard payload.
Active Ingredient Strength Primary Clinical Function Chlorambucil USP/Ph.Eur. 2 mg The Standard Hematology Anchor: The definitive unit utilized for chronic, daily maintenance and precise titration in CLL and low-grade lymphomas. Chlorambucil USP/Ph.Eur. 5 mg The Pulse-Dosing Payload: High-efficacy therapeutic payload utilized for “Pulse” therapy regimens or initial aggressive induction phases. Excipients Lactose Anhydrous / Colloidal Silicon Dioxide / Magnesium Stearate / Hypromellose / Titanium Dioxide / Premium Polymeric Film Diluent / Glidant / Lubricant / Protective Cytotoxic Shield (Engineered specifically utilizing an impenetrable film coat. This ensures the highly toxic, mutagenic API never comes into contact with the skin of the pharmacist or caregiver handling the medication). *Pack Sizes: 25-Tablet or 30-Tablet Bottles/Blisters (Optimized for oncology-specific treatment cycles).
Darifenacin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Prolonged-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Darifenacin Hydrobromide USP/Ph.Eur.
(Equivalent to Darifenacin base)7.5 mg (PR) The Standard Titration & Geriatric Anchor: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients to control OAB symptoms with minimal side effects. Darifenacin Hydrobromide USP/Ph.Eur. 15 mg (PR) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for patients who require greater symptom relief and have demonstrated high tolerability to the 7.5 mg dose. Excipients Hypromellose (HPMC) / Dibasic Calcium Phosphate / Magnesium Stearate / Polyethylene Glycol / Titanium Dioxide / Premium Polymeric Film Hydrophilic PR Matrix / Diluent / Lubricant / Plasticizer / Opaque Film (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastrointestinal fluids, the tablet hydrates to form a thick, gelatinous outer layer that strictly controls the diffusion of the highly soluble hydrobromide salt over a 24-hour period) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic urological dispensing regimens).
Desvenlafaxine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrophilic Matrix Extended-Release Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical and physical stability of the controlled-release polymer.
Active Ingredient Strength Primary Clinical Function Desvenlafaxine Succinate USP/Ph.Eur.
(Equivalent to Desvenlafaxine base)50 mg (ER) The Global Therapeutic Standard: The definitive, highly efficacious starting and maintenance dose utilized for the vast majority of patients suffering from Major Depressive Disorder. Desvenlafaxine Succinate USP/Ph.Eur. 100 mg (ER) The Severe Refractory Macrodose: High-efficacy therapeutic payload utilized strictly for severe, treatment-resistant depression where maximum norepinephrine reuptake inhibition is required. Excipients Hypromellose (HPMC) / Microcrystalline Cellulose / Talc / Magnesium Stearate / Premium Polymeric Film Hydrophilic ER Matrix / Diluent / Glidant / Lubricant / Film-Coating (Engineered specifically utilizing high-viscosity Hypromellose. Upon contact with gastric fluid, the tablet forms a thick, gelatinous outer layer that slowly erodes over 24 hours, guaranteeing a smooth, flat pharmacokinetic curve to prevent violent nausea and serotonin spikes) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day psychiatric dispensing regimens).
Divalproex Sodium Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical survival of the intensely hygroscopic active ingredient.
Active Ingredient Strength Primary Clinical Function Divalproex Sodium USP/Ph.Eur. 250 mg (DR / ER) The Titration & Pediatric Standard: The definitive unit utilized for careful initial dose titration in adult bipolar patients or weight-based dosing for pediatric epilepsy. Divalproex Sodium USP/Ph.Eur. 500 mg (DR / ER) The Neurology Macrodose: Massive therapeutic payload utilized for the aggressive, sustained suppression of chronic complex partial seizures and acute bipolar mania. Excipients (Enteric DR Formulation) Microcrystalline Cellulose / Croscarmellose Sodium / Povidone / Methacrylic Acid Copolymer (Eudragit) / Triethyl Citrate / Titanium Dioxide Diluent / Superdisintegrant / Binder / Enteric Polymer / Plasticizer / Opaque Film (Engineered specifically utilizing advanced fluid-bed enteric coating to completely shield the highly corrosive valproate compound from the stomach, ensuring the pill only dissolves in the alkaline environment of the small intestine to prevent severe gastric bleeding and vomiting) *Pack Sizes: 10×10 Alu-Alu Blisters or Heavy-Gauge HDPE Bottles (Optimized specifically for strict chronic neurology and psychiatry dispensing regimens).
Mesalazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, pH-Targeted PR Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly oxidative 5-ASA molecule.
Active Ingredient Strength Primary Clinical Function Mesalazine (5-ASA) USP/Ph.Eur. 400 mg (PR) Initiation / Titration Standard: Base therapeutic unit for mild presentations or pediatric titration in pediatric gastroenterology. Mesalazine (5-ASA) USP/Ph.Eur. 800 mg / 1200 mg (PR) Global Gastroenterology Standard: High-efficacy adult maintenance doses designed to improve patient compliance by drastically reducing the daily pill burden. Excipients Methacrylic Acid Copolymer Type B & C (Eudragit L/S) / Hypromellose / Triethyl Citrate / Iron Oxide Colors / Talc Enteric & Prolonged-Release Polymers / Plasticizer / Glidant (Engineered specifically to form an impenetrable, acid-resistant shield that strictly delays drug release until reaching the high-pH environment of the lower gastrointestinal tract)
